ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "modifiable risk and environmental factors"

  • Abstract Number: 2075 • 2019 ACR/ARP Annual Meeting

    Cross-sectional Study and Mendelian Randomization Analysis of Diet in Six Prevalent Autoimmune Diseases

    Antonio Julià1, Sergio H Martinez 2, Jesús Tornero 3, Juan Cañete 4, Antonio Fernández-Nebro 5, Francisco J. Blanco 6, Jesús Rodríguez 7, Francisco Javier Lopez-Longo 8, Benjamín Fernandez-Gutierrez 9, Jordi Gratacós 10, Jose J Pérez Venegas 11, Carolina Pérez 12, Ruben Queiró 13, Alejandro Olivé-Marqués 14, Mercedes Alperi-López 15, Carlos Montilla 16, José Luís Andreu 17, Juan Carlos Torre-Alonso 18, Mª Ángeles Aguirre-Zamorano 19, Hèctor Corominas 20, Paloma Vela 21, Víctor Martínez-Taboada 22, Sara Marique 23, Joan M Nolla 24, Isidoro Gonzalez 25, Santiago Muñoz-Fernandez 26, José Luís Marenco de la Fuente 27, Carlos González 28, Antonio Zea 29, Maria Lopez Lasanta 30, Daniel Roig 31, Jose Maria Pego-Reigosa 32, Mireia Lopez Corbeto 33, Pedro Zarco 34, Mercedes Freire González 35, Alba Erra 36, Elvira Díez 37, Santos Castañeda 38, Esther Rodriguez 39, Alicia García 40, Patricia Carreira 39, Georgina Salvador 41, Ricardo Blanco 42, Cesar Diaz-Torne 43, Alfredo Willisch Domínguez 44, Joan Antonio Mosquera 45, Simón Sánchez-Fernández 46, Júlio Ramírez 47 and Sara Marsal 48, 1Rheumatology Research Group, Vall d’Hebron Hospital Research Institute, Barcelona, Spain., Barcelona, Catalonia, Spain, 2Hospital Vall d'Hebron, Barcelona, Barcelona, Spain, 3Hospital Universitario Guadalajara, Guadalajara, Spain., Guadalajara, Castilla-La Mancha, Spain, 4Rheumatology Department, Hospital Clínic and IDIBAPS,, Barcelona, Spain, 5Hospital Carlos Haya, Malaga, Spain, 6Servicio de Reumatología. Instituto de Investigación Biomédica de A Coruña (INIBIC). Complexo Hospitalario Universitario de A Coruña (CHUAC), Sergas. Universidade da Coruña (UDC). As Xubias, 15006. A Coruña, España, A Coruña, Spain, 7Hospital Universitario de Bellvitge, Hospitalet, Spain, 8Hospital Universitario Gregorio Marañón, Madrid, Madrid, Spain, 9Hospital Clínico San Carlos, Madrid, Madrid, Spain, 10Hospital Parc Taulí, Sabadell, Catalonia, Spain, 11Hospital Jerez de la Frontera, Jerez de la Frontera, Spain, 12Parc de Salut Mar, Barcelona, Barcelona, Spain, 13Hospital Universitario Central de Asturias, Oviedo, Oviedo, Spain, 14Hospital Universitari Germans Trias i Pujol, Badalona, Catalonia, Spain, 15Hospital Universitario Central de Asturias, Oviedo, Spain, 16Hospital Clínico Universitario de Salamanca, Salamanca, Spain, 17Hospital Puerta de Hierro, Madrid, Madrid, Spain, 18Hospital Monte Naranco, Oviedo, Spain, 19IMIBIC/Reina Sofia Hospital/University of Cordoba, Córdoba, Spain, 20Hospital de la Santa Creu i Sant Pau, Barcelona, Barcelona, Spain, 21Hospital General Universitario de Alicante, Alicante, Spain, 22Hospital Universitario Marqués de Valdecilla, Santander, Spain, 23Hospital Regional Univeristario de Málaga, Málaga, Spain, 24Hospital Universitari de Bellvitge, Hospitalet, Spain, 25Hospital Universitario La Princesa, Madrid, Spain, 26Hospital Universitario Infanta Sofía, Madrid, Madrid, Spain, 27Hospital Valme, Sevilla, Sevilla, Spain, 28Hospital Universitario Gregorio Marañón, Madrid, Spain, 29Hospital Universitario Ramón y Cajal, Madrid, Madrid, Spain, 30Hospital Universitari Vall Hebrón, Barcelona, Barcelona, Catalonia, Spain, 31Hospital Moisès Broggi, Barcelona, Sant Joan Despí, Barcelona, Singapore, 32Complexo Hospitalario Universitario, Vigo, Spain, 33Hospital Universitari Vall d'Hebron, Barcelona, Catalonia, Spain, 34Hospital Universitario Fundación Alcorcón, Madrid, Madrid, Spain, 35Hospital Universitario Juan Canalejo, La Coruña, Spain, 36H Sant Rafael, Barcelona, Barcelona, Spain, 37Complejo Asistencial Universitario de León, León, Castilla y Leon, Spain, 38Rheumatology, Hospital Universitario La Princesa, Madrid, Madrid, Spain, 39Hospital Universitario 12 de Octubre, Madrid, Spain, 40Centro de Salud Virgen de los Reyes, Sevilla, Sevilla, Spain, 41Hospital Mútua Terrassa, Terrassa, Spain, 42Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain, 43Hospital de la Santa Creu i Sant Pau, barcelona, Catalonia, Spain, 44Complexo Hospitalario de Ourense, Ourense, Spain, 45Complejo Hospitalario Hospital Provincial de Pontevedra, Pontevedra, Spain, 46Hospital La Mancha Centro, Alcázar de San Juan, Alcázar de San Juan, Spain, 47Hospital Clínic de Barcelona, Barcelona, Spain, 48Vall d’Hebron Hospital, Barcelona, Catalonia, Spain

    Background/Purpose: Autoimmune diseases (AD) are complex diseases associated with both genetic and environmental risk factors. In the last 10 years major advances have been made…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology